Cargando…

Evaluation of the dose variation for prostate heavy charged particle therapy using four-dimensional computed tomography

We quantified dose variation effects due to respiratory-induced intrafractional motion in conventional carbon-ion prostate treatment by using four-dimensional computed tomography (4DCT). 4DCT scans of 20 patients were acquired under free-breathing conditions using a 256 multi-slice CT scanner. The c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumagai, Motoki, Okada, Tohru, Mori, Shinichiro, Kandatsu, Susumu, Tsuji, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589943/
https://www.ncbi.nlm.nih.gov/pubmed/23263729
http://dx.doi.org/10.1093/jrr/rrs106
_version_ 1782261806535802880
author Kumagai, Motoki
Okada, Tohru
Mori, Shinichiro
Kandatsu, Susumu
Tsuji, Hiroshi
author_facet Kumagai, Motoki
Okada, Tohru
Mori, Shinichiro
Kandatsu, Susumu
Tsuji, Hiroshi
author_sort Kumagai, Motoki
collection PubMed
description We quantified dose variation effects due to respiratory-induced intrafractional motion in conventional carbon-ion prostate treatment by using four-dimensional computed tomography (4DCT). 4DCT scans of 20 patients were acquired under free-breathing conditions using a 256 multi-slice CT scanner. The clinical target volume (CTV) was defined as the prostate and the seminal vesicle. Two types of planning target volumes (PTVs) were defined to minimize excessive dose to the rectum. The first PTV (= PTV1) was calculated by adding a 3D uniform margin to the CTV. The second PTV (= PTV2) was cut in a straight line from the top surface of the rectum from PTV1. Compensating boli were designed for the respective PTVs at the peak-exhalation phase, and carbon-ion dose distributions for a single respiratory cycle were calculated using these boli. Dose conformation to prostate, CTV, PTV1 and PTV2 were unchanged for all respiratory phases. The dose for >95% volume irradiation (D95) was 97.7% for prostate, 92.5% for CTV, 74.1% for PTV1 and 96.1% for PTV2 averaged over all patients. The rectum volume at inhalation phase receiving ≤50% of the prescribed dose was smaller than the planning dose due to the abdominal thickness variation. The target dose is not affected by intrafractional respiration in carbon-ion prostate treatment. Small dose variations, however, were observed due to respiratory-induced abdominal thickness variation; therefore the geometrical changes should be considered for prostate particle therapy.
format Online
Article
Text
id pubmed-3589943
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-35899432013-03-06 Evaluation of the dose variation for prostate heavy charged particle therapy using four-dimensional computed tomography Kumagai, Motoki Okada, Tohru Mori, Shinichiro Kandatsu, Susumu Tsuji, Hiroshi J Radiat Res Technology We quantified dose variation effects due to respiratory-induced intrafractional motion in conventional carbon-ion prostate treatment by using four-dimensional computed tomography (4DCT). 4DCT scans of 20 patients were acquired under free-breathing conditions using a 256 multi-slice CT scanner. The clinical target volume (CTV) was defined as the prostate and the seminal vesicle. Two types of planning target volumes (PTVs) were defined to minimize excessive dose to the rectum. The first PTV (= PTV1) was calculated by adding a 3D uniform margin to the CTV. The second PTV (= PTV2) was cut in a straight line from the top surface of the rectum from PTV1. Compensating boli were designed for the respective PTVs at the peak-exhalation phase, and carbon-ion dose distributions for a single respiratory cycle were calculated using these boli. Dose conformation to prostate, CTV, PTV1 and PTV2 were unchanged for all respiratory phases. The dose for >95% volume irradiation (D95) was 97.7% for prostate, 92.5% for CTV, 74.1% for PTV1 and 96.1% for PTV2 averaged over all patients. The rectum volume at inhalation phase receiving ≤50% of the prescribed dose was smaller than the planning dose due to the abdominal thickness variation. The target dose is not affected by intrafractional respiration in carbon-ion prostate treatment. Small dose variations, however, were observed due to respiratory-induced abdominal thickness variation; therefore the geometrical changes should be considered for prostate particle therapy. Oxford University Press 2013-03 2012-12-21 /pmc/articles/PMC3589943/ /pubmed/23263729 http://dx.doi.org/10.1093/jrr/rrs106 Text en © The Author 2012. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Therapeutic Radiology and Oncology http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited
spellingShingle Technology
Kumagai, Motoki
Okada, Tohru
Mori, Shinichiro
Kandatsu, Susumu
Tsuji, Hiroshi
Evaluation of the dose variation for prostate heavy charged particle therapy using four-dimensional computed tomography
title Evaluation of the dose variation for prostate heavy charged particle therapy using four-dimensional computed tomography
title_full Evaluation of the dose variation for prostate heavy charged particle therapy using four-dimensional computed tomography
title_fullStr Evaluation of the dose variation for prostate heavy charged particle therapy using four-dimensional computed tomography
title_full_unstemmed Evaluation of the dose variation for prostate heavy charged particle therapy using four-dimensional computed tomography
title_short Evaluation of the dose variation for prostate heavy charged particle therapy using four-dimensional computed tomography
title_sort evaluation of the dose variation for prostate heavy charged particle therapy using four-dimensional computed tomography
topic Technology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589943/
https://www.ncbi.nlm.nih.gov/pubmed/23263729
http://dx.doi.org/10.1093/jrr/rrs106
work_keys_str_mv AT kumagaimotoki evaluationofthedosevariationforprostateheavychargedparticletherapyusingfourdimensionalcomputedtomography
AT okadatohru evaluationofthedosevariationforprostateheavychargedparticletherapyusingfourdimensionalcomputedtomography
AT morishinichiro evaluationofthedosevariationforprostateheavychargedparticletherapyusingfourdimensionalcomputedtomography
AT kandatsususumu evaluationofthedosevariationforprostateheavychargedparticletherapyusingfourdimensionalcomputedtomography
AT tsujihiroshi evaluationofthedosevariationforprostateheavychargedparticletherapyusingfourdimensionalcomputedtomography